SyResp (Syntrion GmbH)


Welcome to the PulseAid listing for the SyResp drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.

LABELER NAME / MANUFACTURER: Syntrion GmbH
NON-PROPRIETARY NAME: ASPERGILLUS NIGER VAR. NIGER
SUBSTANCE NAME: ASPERGILLUS NIGER VAR. NIGER
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-02-11
END MARKETING DATE: 2020-08-31


SyResp HUMAN OTC DRUG Details:

Item DescriptionSyResp from Syntrion GmbH
LABELER NAME: Syntrion GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2015-02-11
END MARKETING DATE: 2020-08-31
PRODUCT ID: 10424-110_5f644c1a-3765-4126-9d41-2bd2c7b7f4b2
PRODUCT NDC: 10424-110
APPLICATION NUMBER:

Other ASPERGILLUS NIGER VAR. NIGER Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALK-Abello, Inc.ASPERGILLUS NIGER VAR NIGER
Allergy Laboratories, Inc.ASPERGILLUS NIGER
Allermed Laboratories, Inc.Aspergillus niger
Antigen Laboratories, Inc.Aspergillus niger
BioResource Inc.Aspergillus
Energique, Inc.Aspergillus Niger
Jubilant HollisterStier LLCMolds, Rusts and Smuts, Aspergillus niger
Nelco Laboratories, Inc.Aspergillus niger
sanPharma GmbHAsperSAN
Sanum Kehlbeck GmbH & Co. KGPleo Nig
Sanum-Kehlbeck GmbH & Co. KGPleo Nig
SymbiopathicSYMBIO ASPER DROPS
Syntrion GmbHSyResp
USPharmaCoAspergillus